港股异动︱次新股沛嘉医疗-B(09996) 续涨逾 5% 创新高 获大摩首予 “买入” 评级

智通财经 · 2020-06-30
次新股沛嘉医疗-B(09996) 暂现五连阳,累计涨幅超 20%,盘中以 37.75 港元创新高,截至 11 时 00 分,涨 5.45%,报价 37.75 港元,成交额 5174.93 万。

智通财经 APP 获悉,次新股沛嘉医疗-B(09996) 暂现五连阳,累计涨幅超 20%,盘中以 37.75 港元创新高,截至 11 时 00 分,涨 5.45%,报价 37.75 港元,成交额 5174.93 万。

大摩发布研究报告,首予其 “增持” 评级,目标价看至 33.6 港元。并表示公司拥有 10 个心脏产品及 16 个神经血管产品,预计其丰富的产品管线将推动销售增长,预计公司今年收入为 3500 万元人民币,明年 1.67 亿元人民币,并有望于 2022 年实现盈利。

Long Bridge Securities Ltd is a New Zealand registered Financial Service Provider (FSP number: FSP600050), and is a member of the Financial Dispute Resolution Scheme, a New Zealand independent dispute resolution service provider.

All data and contents of the Long Bridge website (longbridge.global) are for investors' reference only. Before conducting investment activities, investors should fully understand the relevant products, clearly know their potential risks, and make rational decisions based on their own risk tolerance; and investors should be aware that all investment activities involve risks and investment activities may not be suitable for every investor.

Customer Service (Only for general enquiries):400-071-2688

0800 33 9033 / (09) 533 9033(New Zealand)

Support Email: service@longbridge.global
简体中文